UnitedHealth Group (NYSE: UNH) is set to report its second-quarter earnings on Thursday, July 17, with analysts expecting earnings per share (EPS) of $4.85 and revenue of $110.77 billion. This follows a strong performance in the previous quarter, where the company reported an EPS of $7.23, exceeding estimates of $6.56, and revenue of $111.72 billion, surpassing the expected $109.57 billion, according to Benzinga.
Analyst Ratings
Recent analyst activity has shown a mix of optimism and caution. The stock currently holds a Buy rating with an average price target of $432.63. TD Cowen raised its target to $430 on July 14, while Truist Securities increased its target to $480, and Keybanc raised its target to $475 on the same day. However, shares of UnitedHealth are under pressure, trading 2.20% lower at $415.85 ahead of the earnings report.
Market Sentiment
Investors are particularly focused on trends in Medicare Advantage membership and pricing, which are seen as critical to supporting revenue growth. Additionally, growth in Optum's services and pharmacy benefit businesses will be crucial to offset any potential stagnation in consolidated revenue. Analysts have noted that the macroeconomic environment remains a tailwind for the healthcare sector, but any negative surprises in the earnings report could impact stock performance.
Related coverage: AMD Stock Rises as Analysts Boost Price Forecasts to $675.
The upcoming earnings report is likely to influence healthcare stocks, particularly those tied to Medicare Advantage and pharmacy benefits, as investors assess UnitedHealth's performance and guidance. A weaker-than-expected report could lead to downward pressure on shares across the sector.
Watch for the earnings report on July 17, which will provide insights into the company's growth prospects and market positioning.